Showing results (5261-5270 of 5,703) with videos related to

Sort By:
Pageof 571
The Oncologist|October 12, 2020
FDA Supplemental Approval Summary: Lenvatinib for the Treatment of Unresectable Hepatocellular CarcinomaAbhilasha Nair, Kelie Reece, Martha B Donoghue, et al.
The Oncologist|October 28, 2020
Dramatic Changes in Oncology Care Pathways During the COVID-19 Pandemic: The French ONCOCARE-COV StudyMathias Brugel, Claire Carlier, Christine Essner, et al.
The Oncologist|October 26, 2020
A Phase I Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Patients with Select Advanced Solid TumorsYuxiang Ma, Wenfeng Fang, Hongyun Zhao, et al.
The Oncologist|October 6, 2020
Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management GuidelinesMario E Lacouture, Vincent Sibaud, Milan J Anadkat, et al.
The Oncologist|October 8, 2020
Impact of Primary Tumor Location on Survival After Curative Resection in Patients with Colon Cancer: A Meta-Analysis of Propensity Score-Matching StudiesMitsuru Ishizuka, Takayuki Shimizu, Norisuke Shibuya, et al.
The Oncologist|October 5, 2020
Nivolumab-Induced Thrombotic Thrombocytopenic Purpura in a Patient with Anal Squamous Cell Carcinoma: A Lesson on Hematologic Toxicity from ImmunotherapyMansour Gergi, Kara K Landry, Steven Ades, et al.
The Oncologist|October 5, 2020
Safety and Preliminary Efficacy of Ramucirumab in Combination with FOLFOX4 in Patients with Advanced Hepatocellular Carcinoma: A Nonrandomized, Open-Label, Phase Ib StudyChia-Chi Lin, Tsai-Sheng Yang, Chia-Jui Yen, et al.
The Oncologist|October 5, 2020
FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian CancerShaily Arora, Sanjeeve Balasubramaniam, Hui Zhang, et al.
The Oncologist|September 30, 2020
Metastatic Low-Grade Sarcoma with CARS-ALK Fusion Dramatically Responded to Multiple ALK Tyrosine Kinase Inhibitors: A Case Report with Comprehensive Genomic AnalysisXiao-Dong Jiao, Ke Liu, Mingyan Xu, et al.
The Oncologist|October 1, 2020
Neoadjuvant Pyrotinib plus Trastuzumab and Chemotherapy for Stage I-III HER2-Positive Breast Cancer: A Phase II Clinical TrialJuncheng Xuhong, Xiaowei Qi, Peng Tang, et al.
Pageof 571